Your browser doesn't support javascript.
loading
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
Tap, William D; Wagner, Andrew J; Schöffski, Patrick; Martin-Broto, Javier; Krarup-Hansen, Anders; Ganjoo, Kristen N; Yen, Chueh-Chuan; Abdul Razak, Albiruni R; Spira, Alexander; Kawai, Akira; Le Cesne, Axel; Van Tine, Brian A; Naito, Yoichi; Park, Se Hoon; Fedenko, Alexander; Pápai, Zsuzsanna; Soldatenkova, Victoria; Shahir, Ashwin; Mo, Gary; Wright, Jennifer; Jones, Robin L.
Afiliação
  • Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Wagner AJ; Department of Medicine, Weill Cornell Medical College, New York, New York.
  • Schöffski P; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Martin-Broto J; University Hospitals Leuven, Department of General Medical Oncology, Leuven Cancer Institute, Leuven, Belgium.
  • Krarup-Hansen A; Medical Oncology Department in University Hospital Virgen del Rocio and Institute of Biomedicine of Sevilla (IBIS) (HUVR, CSIC, University of Sevilla), Sevilla, Spain.
  • Ganjoo KN; University of Copenhagen, Copenhagen, Denmark.
  • Yen CC; Stanford University, Stanford, California.
  • Abdul Razak AR; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Spira A; National Yang-Ming University School of Medicine, Taipei, Taiwan.
  • Kawai A; Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Le Cesne A; Virginia Cancer Specialists, Fairfax.
  • Van Tine BA; National Cancer Center Hospital, Tokyo, Japan.
  • Naito Y; Institut Gustave Roussy, Villejuif, France.
  • Park SH; Department of Internal Medicine, Washington University in St Louis School of Medicine, St Louis, Missouri.
  • Fedenko A; National Cancer Center Hospital East, Kashiwa, Japan.
  • Pápai Z; Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea.
  • Soldatenkova V; Blokhin Cancer Research Center, Moscow, Russian Federation.
  • Shahir A; Magyar Honvedseg Eu Kp, Budapest, Hungary.
  • Mo G; Eli Lilly and Company, Indianapolis, Indiana.
  • Wright J; Eli Lilly and Company, Windlesham, United Kingdom.
  • Jones RL; Eli Lilly and Company, Indianapolis, Indiana.
JAMA ; 323(13): 1266-1276, 2020 04 07.
Article em En | MEDLINE | ID: mdl-32259228
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antibióticos Antineoplásicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoma / Protocolos de Quimioterapia Combinada Antineoplásica / Doxorrubicina / Antibióticos Antineoplásicos / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2020 Tipo de documento: Article